10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.

      European Journal of Pharmacology
      Animals, Apoptosis, drug effects, Behavior, Animal, Caspase 3, metabolism, Caspase 8, Cell Death, Cerebellum, cytology, Cistanche, chemistry, Disease Models, Animal, Dopamine, Dose-Response Relationship, Drug, Glycosides, administration & dosage, pharmacology, MPTP Poisoning, drug therapy, Male, Mice, Mice, Inbred C57BL, Neurons, Neuroprotective Agents, Parkinson Disease, Secondary, chemically induced, Plant Extracts, Tyrosine 3-Monooxygenase

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the present study, we investigated the neuroprotective effects of echinacoside, a phenylethanoid glycoside extracted from the medicinal Chinese herb Cistanches salsa, against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity. We confirmed that exposure to MPTP in mice leads to permanent behavioral deficits and depletion of dopamine and its metabolites. When administered prior to MPTP, echinacoside reduced behavioral deficits, increased striatal dopamine and dopamine metabolite levels, reduced cell death, and led to a marked increase in tyrosine hydroxylase expression relative to mice treated with MPTP alone. In addition, pre-treatment with echinacoside significantly reduced caspase-3 and caspase-8 activation in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in cerebellar granule neurons. Taken together, these findings suggest that echinacoside improves the behavioral and neurochemical outcomes in MPTP mice model of Parkinson's disease and inhibits caspase-3 and caspase-8 activation in cerebellar granule neurons, making the compound an attractive candidate treatment for various neurodegenerative disorders, including Parkinson's disease.

          Related collections

          Author and article information

          Comments

          Comment on this article